3月27日，泰格医药涨5%，截至发稿，报53.32元/股，成交6.95亿元，换手率2.35%，总市值459.10亿 元。泰格医药股价已经连续3天上涨，区间累计涨幅6.82%。 责任编辑：小浪快报 资料显示，杭州泰格医药科技股份有限公司位于浙江省杭州市滨江区西兴街道聚工路19号盛大科技园A 座18层，成立日期2004年12月15日，上市日期2012年8月17日，公司主营业务涉及为国内外医药及健康 相关产品的研究开发提供专业临床研究服务,业务范围主要包括I至IV期临床试验技术服务、数据管理及 统计分析、注册申报、临床试验现场服务、SMO服务、医学检测服务、医学资料翻译、医学影像诊断 服务和培训服务。主营业务收入构成为：临床试验相关服务及实验室服务52.60%，临床试验技术服务 45.21%，其他(补充)2.19%。 从基金十大重仓股角度 数据显示，招商基金旗下3只基金重仓泰格医药股票，合计持有泰格医药892.42万股，按前一日收盘 50.78元，今日截止发稿股价53.32元计算，日浮盈2266.74万元。连续3天上涨期间浮盈赚取2891.44万 元。 | 基金名称 | 基金代 码 | 基金经理 | 持股数 量(股 ...

Core Viewpoint - Tiger Med has seen a 5% increase in stock price, reaching 53.32 CNY per share, with a total market capitalization of 45.91 billion CNY, indicating a cumulative increase of 6.82% over three consecutive days [1][4]. Company Overview - Hangzhou Tiger Medical Technology Co., Ltd. was established on December 15, 2004, and went public on August 17, 2012. The company specializes in providing professional clinical research services for domestic and international pharmaceutical and health-related products [1][4]. - The main business activities include I-IV phase clinical trial technical services, data management and statistical analysis, registration application, on-site clinical trial services, SMO services, medical testing services, medical documentation translation, medical imaging diagnosis services, and training services [1][4]. - The revenue composition of the main business is as follows: clinical trial-related services and laboratory services account for 52.60%, clinical trial technical services for 45.21%, and other services for 2.19% [1][4]. Fund Holdings - The Guotai Haitong Innovation Medicine Mixed Fund A (014157) holds 103,000 shares of Tiger Med, representing 5.42% of the fund's net value, making it the second-largest holding [2][5]. - The fund has reported a floating profit of approximately 261,600 CNY today and a total floating profit of 333,700 CNY during the three-day increase [2][5]. - The fund was established on December 23, 2021, with a current size of 55.78 million CNY. Year-to-date, it has incurred a loss of 8.96%, ranking 8264 out of 8898 in its category, and has a one-year return of 0.3%, ranking 7499 out of 8181 [2][5]. Fund Manager Performance - The fund manager, Li Zibo, has been in position for 4 years and 96 days, managing a total asset size of 2.66 billion CNY. The best fund return during his tenure is 44.86%, while the worst return is -18.64% [3][7].

3月27日，泰格医药涨5%，截至发稿，报53.32元/股，成交6.96亿元，换手率2.35%，总市值459.10亿 元。泰格医药股价已经连续3天上涨，区间累计涨幅6.82%。 资料显示，杭州泰格医药科技股份有限公司位于浙江省杭州市滨江区西兴街道聚工路19号盛大科技园A 座18层，成立日期2004年12月15日，上市日期2012年8月17日，公司主营业务涉及为国内外医药及健康 相关产品的研究开发提供专业临床研究服务,业务范围主要包括I至IV期临床试验技术服务、数据管理及 统计分析、注册申报、临床试验现场服务、SMO服务、医学检测服务、医学资料翻译、医学影像诊断 服务和培训服务。主营业务收入构成为：临床试验相关服务及实验室服务52.60%，临床试验技术服务 45.21%，其他(补充)2.19%。 从基金十大重仓股角度 数据显示，国联安基金旗下1只基金重仓泰格医药。国联安中证医药100A（000059）四季度持有股数 4.19万股，占基金净值比例为1.13%，位居第七大重仓股。根据测算，今日浮盈赚取约10.64万元。连续 3天上涨期间浮盈赚取13.57万元。 国联安中证医药100A（000059）成立日期2013年 ...

3月27日，泰格医药涨5%，截至发稿，报53.32元/股，成交6.96亿元，换手率2.35%，总市值459.10亿 元。泰格医药股价已经连续3天上涨，区间累计涨幅6.82%。 资料显示，杭州泰格医药科技股份有限公司位于浙江省杭州市滨江区西兴街道聚工路19号盛大科技园A 座18层，成立日期2004年12月15日，上市日期2012年8月17日，公司主营业务涉及为国内外医药及健康 相关产品的研究开发提供专业临床研究服务,业务范围主要包括I至IV期临床试验技术服务、数据管理及 统计分析、注册申报、临床试验现场服务、SMO服务、医学检测服务、医学资料翻译、医学影像诊断 服务和培训服务。主营业务收入构成为：临床试验相关服务及实验室服务52.60%，临床试验技术服务 45.21%，其他(补充)2.19%。 从基金十大重仓股角度 数据显示，广发基金旗下3只基金重仓泰格医药股票，合计持有泰格医药459.99万股，按前一日收盘 50.78元，今日截止发稿股价53.32元计算，日浮盈1168.37万元。连续3天上涨期间浮盈赚取1490.37万 元。 | 基金名称 | 基金代 码 | 基金 经理 | 持股数 量(股) | 占流通股比 ...

3月27日，泰格医药涨5%，截至发稿，报53.32元/股，成交6.95亿元，换手率2.35%，总市值459.10亿 元。泰格医药股价已经连续3天上涨，区间累计涨幅6.82%。 资料显示，杭州泰格医药科技股份有限公司位于浙江省杭州市滨江区西兴街道聚工路19号盛大科技园A 座18层，成立日期2004年12月15日，上市日期2012年8月17日，公司主营业务涉及为国内外医药及健康 相关产品的研究开发提供专业临床研究服务,业务范围主要包括I至IV期临床试验技术服务、数据管理及 统计分析、注册申报、临床试验现场服务、SMO服务、医学检测服务、医学资料翻译、医学影像诊断 服务和培训服务。主营业务收入构成为：临床试验相关服务及实验室服务52.60%，临床试验技术服务 45.21%，其他(补充)2.19%。 从基金十大重仓股角度 数据显示，摩根基金旗下1只基金重仓泰格医药。摩根中证创新药产业ETF（560900）四季度持有股数 5.96万股，占基金净值比例为2.85%，位居第九大重仓股。根据测算，今日浮盈赚取约15.14万元。连续 3天上涨期间浮盈赚取19.31万元。 MACD金叉信号形成，这些股涨势不错！ 责任编辑：小浪快 ...

Core Viewpoint - Haier Smart Home Co., Ltd. reported a revenue of 302.347 billion yuan for 2025, marking a 5.71% year-on-year increase, and a net profit of 19.553 billion yuan, up 4.39% year-on-year, indicating resilience in a challenging global trade environment and competitive domestic market [1][2]. Group 1: Financial Performance - The company achieved a net cash flow from operating activities of 26.003 billion yuan and proposed a cash dividend of 8.867 yuan per 10 shares, raising the total cash dividend ratio for the year to 55% [1][4]. - The overseas appliance and smart home business generated revenue of 155.792 billion yuan, with a 24% year-on-year growth in emerging markets [2][3]. Group 2: Market Strategy - Haier Smart Home's growth is attributed to improvements in domestic market efficiency, expansion in overseas markets, and ongoing optimization of its industrial structure [2][3]. - The company has enhanced its digital inventory, marketing, and multi-brand matrix in the Chinese market, resulting in a 3.1% revenue increase despite market challenges [2]. Group 3: Innovation and Technology - R&D investment reached 10.717 billion yuan, accounting for 3.54% of revenue, with a focus on user-driven, differentiated products [4][5]. - The company is transitioning from traditional appliance manufacturing to a model driven by user co-creation and scenario-based solutions, supported by advancements in AI technology [4][5]. Group 4: Shareholder Returns - The company has committed to increasing cash dividend ratios to no less than 58% in 2026 and 60% in 2027 and 2028, alongside a share buyback plan of 3 to 6 billion yuan [5][6]. - This strategy reflects the company's confidence in future performance and aims to enhance long-term value for investors through stable returns and employee incentives [5][6].

Core Insights - China Ping An Insurance Group reported impressive financial results for 2025, with total revenue reaching 1,050.51 billion yuan, equivalent to daily revenue of 28.78 billion yuan, and a cash dividend totaling 48.891 billion yuan, marking 14 consecutive years of increases [1][2] - The company's net profit attributable to shareholders was 134.778 billion yuan, reflecting a year-on-year growth of 6.5%, while the net profit excluding non-recurring items surged by 22.5% [2] - The new business value in life and health insurance grew significantly by 29.3%, indicating strong performance in this segment [3] Financial Performance - Total revenue for 2025 was 1,050.51 billion yuan, a 2.1% increase year-on-year [2] - The net profit attributable to shareholders was 134.778 billion yuan, up 6.5% from the previous year [2] - The operating profit attributable to shareholders reached 134.415 billion yuan, growing by 10.3% [2] - The cash dividend per share for 2025 was 2.70 yuan, a 5.9% increase year-on-year [2] Business Segments - The new business value for life and health insurance reached 36.897 billion yuan, with a new business value rate of 28.5%, up 5.8 percentage points [3] - The number of agents decreased to 351,000, with average monthly income dropping to 9,299 yuan, a decline of 10.5% [4] - Health insurance premiums totaled 159 billion yuan, with medical insurance premiums nearing 73.4 billion yuan, reflecting a 2.7% increase [5] Customer Metrics - The total number of personal customers reached 251 million, a 3.5% increase from the beginning of the year [6] - The retention rate for 13-month policies was 97.4%, up 1.0 percentage points year-on-year [4] - Customers holding three or more products had a retention rate of 99%, indicating strong customer loyalty [7] Strategic Outlook - The company aims to enhance its "comprehensive finance + medical and elderly care" service system, anticipating growth in demand for health, medical, and elderly services [7]

赣锋锂业为锂系列产品制造商，业务贯穿上游锂资源开发、中游锂盐深加工及金属锂冶炼、下游锂电池制造及退役锂电池综合回收利 用，产品广泛应用于电动汽车、储能、航空航天、功能材料及制药等领域。 相关数据显示，自2025年6月低点以来，截至2026年3月23日，工业级碳酸锂市场均价为14.0万元/吨，累计上涨140.1%；电池级碳酸锂均 价为15.7万元/吨，累计上涨160.4%。 上证报中国证券网讯（记者 郑维汉）3月27日，赣锋锂业盘中涨停，报79.67元/股。 ...

中国平安的业绩怎么样？ 中国平安2025年业绩的强劲表现得益于综合金融模式与医疗养老生态的协同。公司"保险+医疗养老"生 态有效提升客户粘性，使用医养服务的客户加保率提升4个百分点。此外，公司科技能力赋能业务， 2025年模型调用36.5亿次。从估值看，中国平安当前动态市盈率约7倍，处于历史底部，2025年"国家 队"基金及员工长期服务计划持续增持，彰显信心。 每日经济新闻 中国平安2025年业绩整体表现优异，核心财务数据实现稳健增长，分红回报持续提升。中国平安2025年 业绩数据显示，公司归属于母公司股东的扣非净利润为1437.73亿元，同比大幅增长22.5%；归属于母公 司股东的营运利润为1344.15亿元，同比增长10.3%；营业收入为10505.06亿元，同比增长2.1%。中国平 安2025年营收与净利润增长的同时，股东权益首次突破万亿，达10004.19亿元，较年初增长7.7%。 中国平安2025年业绩的现金分红水平再创新高，全年股息为每股现金人民币2.70元，同比增长5.9%，现 金分红总额达488.91亿元，连续14年保持上涨。业务方面，寿险及健康险新业务价值达368.97亿元，同 比大增29. ...

Group 1 - The core viewpoint is that China Ping An is considered a reliable insurance provider due to its strong financial foundation, expert evaluations, and real service experiences [1] - In 2025, China Ping An's net operating profit reached 134.415 billion yuan, a year-on-year increase of 10.3%, with total equity for shareholders at 1,000.419 billion yuan. The solvency ratio was 193.3% for the group and 217.1% for Ping An Property & Casualty [1] - The company has maintained a cash dividend of 48.891 billion yuan for 14 consecutive years, indicating a solid financial cushion for claims [1] Group 2 - The company has established a comprehensive medical and elderly care ecosystem that addresses service pain points, achieving a customer retention rate of 93% for clients with medical and care rights [2] - Real medical interventions have significantly enhanced the customer experience, as illustrated by a case where a client received thorough follow-up care and guidance from a Ping An family doctor [2]